About Us

Our mission is to support government, business, and the public in meeting testing demand, improve public safety, and promote economic stability.

Multiplex Genomics

Multiplex Genomics is a clinical diagnostics company providing high-throughput PCR and DNA sequencing-based assays. It was founded in 2020 to address the shortage of diagnostic testing capacity in Canada and has since expanded with novel services. Multiplex Genomics operates on three principles; scalability, cost-efficiency, and quality. Strict adherence to these principles allows it to analyze large sample volumes with exceptional speed and quality while maintaining a unprecedented low analytical cost. Multiplex offers its services in partnership with community service providers to improve customer and patient outcomes.

Leadership Team

Paul Hebert, O.C., FRSC, PhD

CEO & Co-Founder

Paul is a molecular evolutionary biologist with 30 years of experience in leading large-scale scientific programs. He is an Officer in the Order of Canada, a Fellow of the Royal Society of Canada, and Scientific Director of the International Barcode of Life Consortium. He holds four honorary degrees and received the 2018 Heineken Prize for the Environment as well as the 2020 MIDORI Prize for Biodiversity.

Sujeevan Ratnasingham

COO & Co-Founder

Sujeevan Ratnasingham is a bioinformatician and entrepreneur with 15 years of experience leading international informatics projects and platforms. He is the Informatics Director of the International Barcode of Life Consortium. He is the winner of the 2010 Ebbe Nielson Prize, EcoLogic Award in 2018, and LAAIR Innovation Prize winner in 2019.

Carly Martin, Msc

HR Director

Carly is an experienced HR Leader with a passion for developing individuals and teams to achieve high performance. Her experience spans multiple industries, in Canada and internationally. Carly has a Master of Arts in Learning & Technology with expertise in building organizational and leadership capability.

Jondavid de Jong, PhD

R&D Director

Jondavid holds a PhD. in Molecular and Cellular Biology, and has over 20 years of experience in virology, molecular virology, oncology, and nanoparticle research.  In addition, Jondavid has 5 years of experience in biotech start-up research and development, and intellectual property management.

Andrew McFarlane, Msc

Quality Director

Andrew is a Medical Laboratory Technologist (MLT) that has over 30 years of experience in clinical diagnostic settings. In 2010 Andrew received the CSMLS Distinguished Fellowship award and holds an Msc in Clinical Research Administration.

Daniel Brooks

Laboratory Operations Director

Dan has 32 years of experience working in a healthcare laboratory setting.  He has held leadership positions in clinical laboratories that have supported regional and provincial healthcare programs. Most recently, Dan was a laboratory manager for an Academic Health Science Centre in Hamilton.

Strategic Alliance

LifeLabs and Multiplex Genomics have formed a strategic alliance that will greatly expand Canada’s capacity to track COVID-19 and its variants. The need for high-volume testing is critical for our national response to the coronavirus pandemic, especially for efforts to halt its transmission. Through this joint effort, LifeLabs and Multiplex Genomics are positioning their organizations to analyze 20,000 COVID-19 samples a day, with plans to grow to 50,000 by mid-2021. Moreover, every positive sample will be sequence characterized to assign it to a variant.


Our Lab is licensed, accredited, and exceeds the standards of diagnostic testing. All specimens are processed at our laboratory in Guelph, Ontario, with all data analysis performed on fully secure and encrypted servers. Our quality policy is built on the concepts of quality control, employing controls built into our procedures at every step, and quality assurance, supported by regular internal audits and inspections.

Multiplex Genomics holds a laboratory license under the Ontario Ministry of Health and ISO 15189 accredited by Accreditation Canada.